Patients With Multiple Myeloma Develop SOX2-Specific Autoantibodies After Allogeneic Stem Cell Transplantation
Clinical and Developmental Immunology
doi 10.1155/2011/302145
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2011
Authors
Publisher
Hindawi Limited